Dr. Joseph Friedberg
Co-Director of Temple Health Mesothelioma and Pleural Disease Program at Temple University Health System
Dr. Joseph Friedberg co-leads pleural mesothelioma treatment at Temple University Health System, which includes the Fox Chase Cancer Center. He champions pleurectomy with decortication surgery (P/D) and photodynamic therapy.
Fox Chase Cancer Center
333 Cottman Avenue, Philadelphia, PA 19111
JUMP TO A TOPIC
More Information About Mesothelioma Specialist Dr. Joseph Friedberg
Dr. Friedberg is a pleural mesothelioma specialist with a clinical focus on mesothelioma, lung cancer, chest wall tumors, pulmonary metastasis and pneumothorax. His official titles at Temple University Health System are Thoracic Surgeon-in-Chief and Co-Director of the Temple Health Mesothelioma and Pleural Disease Program.
His surgical prevalence with mesothelioma focuses on P/D, which keeps both lungs in the body. Dr. Friedberg is a proponent of using photodynamic therapy with surgery.
Job Change in 2022 to Temple University Health System
Dr. Friedberg joined the Temple University Health System in February of 2022 after working as a thoracic surgeon at the University of Maryland Medical Center in Baltimore. His work included seeing pleural mesothelioma patients through the University of Maryland Comprehensive Cancer Center.
Dr. Friedberg now sees patients through the Temple University Hospital main campus and Fox Chase Cancer Center, both in Philadelphia. His cancer-related responsibilities also include serving as Vice Chair of Surgical Services for the Department of Thoracic Medicine and Surgery. He’s also a Professor of Thoracic Medicine and Surgery at Temple University’s Lewis Katz School of Medicine.
His past includes being a specialist at multiple other cancer centers, and his experience spans more than three decades. Dr. Friedberg worked at Penn Presbyterian Medical Center, which is part of the University of Pennsylvania Health System. He was Chief of Thoracic Surgery and co-director of the Penn Mesothelioma and Pleural Disease Program.
Aside from being a thoracic surgeon at the University of Maryland Cancer Center, he was a professor of surgery and the head of the Division of Thoracic Surgery at University of Maryland School of Medicine. He also previously taught thoracic surgery at the University of Pennsylvania School of Medicine. He has been recognized regularly as a Best Doctor of America since 2009.
- Medical Degree from Harvard Medical School in Boston, 1986
- Research fellowship at Harvard Medical School, 1985
- Internship in Surgery at Massachusetts General Hospital in Boston, 1987
- Residency in General Surgery at Massachusetts General Hospital, 1989
- Research fellowship at Massachusetts General Hospital, 1991
- Residency in General Surgery at Massachusetts General Hospital, 1994
- Fellowship in Cardiothoracic Surgery at Brigham and Women’s Hospital in Boston, 1996
- Memberships in the American Association of Thoracic Surgeons, American College of Chest Physicians and American Society of Clinical Oncology
Get Connected to Dr. Joseph Friedberg
Dr. Joseph Friedberg is a pleurectomy/decortication surgeon. He works at Temple University Health System and Fox Chase Cancer Center, where he co-leads treatment of pleural mesothelioma. His career started 35 years ago with a Medical Degree at Harvard.
Why Choose Dr. Friedberg?
- Proponent of a novel therapy: photodynamic therapy
- Discovery of specific lymph nodes to remove during surgery
- Led mesothelioma programs at multiple cancer centers
Pioneer of Photodynamic Therapy for Mesothelioma
Dr. Friedberg’s research included developing a photodynamic therapy (PDT) for malignant mesothelioma cells. This treatment is a photosensitive drug which kills cancer cells after being exposed to a light beam. PDT could be used before or after surgery.
Lymph Nodes in Rib Cage Discovery
Dr. Friedberg also discovered the importance of lymph nodes in the rib cage. The lymph nodes in this area can carry metastatic cells, making complete surgery difficult if they’re not removed.
“Although larger studies are needed, we believe that these lymph nodes should routinely be removed during any surgery with therapeutic intent for malignant pleural mesothelioma, especially as they may be the only lymph nodes to harbor metastatic disease,” Dr. Friedberg said.
Connect With Dr. Friedberg at Temple University Health System
Dr. Friedberg’s prestige matches with the prestige of Temple University Health System and the Fox Chase Cancer Center. You or your loved one can begin a conversation with him about treatment options.
Our team can help you with the first steps of this process. Email our registered nurse, Karen Ritter, at firstname.lastname@example.org. Another resource is completing a Doctor Match form on our website. This free resource helps us match you with doctors based on your diagnosis, location and more specifics.
Sources & Author
- Dr. Friedberg Named Thoracic Surgeon-in-Chief of Temple University Health System. Temple Health. Retrieved from: https://www.templehealth.org/about/news/dr-joseph-friedberg-named-thoracic-surgeon-in-chief-of-temple-university-health-system. Accessed: 03/01/2022
- Joseph S. Friedberg, MD. University of Maryland School of Medicine. Retrieved from: https://www.medschool.umaryland.edu/profiles/Friedberg-Joseph/. Accessed: 12/14/2021.
- Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma. Annals of Cardiothoracic Surgery. Retrieved from: https://www.annalscts.com/article/view/1214/1605. Accessed: 03/31/2021.
- University of Maryland Thoracic Surgeons Identify Lymph Nodes That May Help To Determine Prognosis for Patients with Pleural Mesothelioma. Newswise. Retrieved from: https://www.newswise.com//articles/university-of-maryland-thoracic-surgeons-identify-lymph-nodes-that-may-help-to-determine-prognosis-for-patients-with-pleural-mesothelioma. Accessed: 2/13/19.